Home › Companies › UNITED THERAPEUTICS CORP. › 2024-2025

UNITED THERAPEUTICS CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

17Reported items
635Asset managers
10,885Fund votes
2025-06-26Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by UNITED THERAPEUTICS CORP.

These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

UNITED THERAPEUTICS CORP. — official shareholder meeting results, meeting held 2025-06-26
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Christopher Causey	34,893,687	5,296,661	16,365	--	1,296,357	Majority: yes
Elect Director: Raymond Dwek	36,254,579	3,935,774	16,360	--	1,296,357	Majority: yes
Elect Director: Richard Giltner	37,971,706	2,218,884	16,123	--	1,296,357	Majority: yes
Elect Director: Ray Kurzweil	38,353,526	1,836,845	16,342	--	1,296,357	Majority: yes
Elect Director: Jan Malcolm	39,688,758	500,264	17,691	--	1,296,357	Majority: yes
Elect Director: Linda Maxwell	39,715,114	474,450	17,149	--	1,296,357	Majority: yes
Elect Director: Nilda Mesa	39,346,176	833,067	27,470	--	1,296,357	Majority: yes
Elect Director: Judy Olian	39,832,045	357,023	17,645	--	1,296,357	Majority: yes
Elect Director: Christopher Patusky	35,613,212	4,577,171	16,330	--	1,296,357	Majority: yes
Elect Director: Martine Rothblatt	37,651,671	2,539,840	15,202	--	1,296,357	Majority: yes
Elect Director: Louis Sullivan	36,302,169	3,875,030	29,514	--	1,296,357	Majority: yes
Elect Director: Tommy Thompson	38,598,138	1,590,040	18,535	--	1,296,357	Majority: yes
Proposal 2: An advisory resolution to approve executive compensation:	38,413,776	1,763,712	29,225	--	1,296,357	Majority: yes
Proposal 3: Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan:	36,901,484	3,277,695	27,534	--	1,296,357	Majority: yes
Proposal 4: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025:	39,345,917	2,142,852	14,301	--	--	Majority: yes

Source: UNITED THERAPEUTICS CORP., Form 8-K — read the filing on EDGAR.

How asset managers voted at the UNITED THERAPEUTICS CORP. 2024-2025 meeting

Each item below shows how the 635 asset managers that disclosed a UNITED THERAPEUTICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of UNITED THERAPEUTICS CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory resolution to approve executive compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 12 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 38,413,776AGAINST: 1,763,712

UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 2: An advisory resolution to approve executive compensation:”): 38,413,776 for, 1,763,712 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 628 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%

FOR: 96.6%AGAINST: 3.4%ABSTAIN: 0.0%NOT VOTED: 0.0%

Largest asset managers voting on “Advisory resolution to approve executive compensation.” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Vote
Vanguard	5,486,649	598	For
BlackRock	4,958,531	293	For
Fidelity	3,313,020	0	For
State Street	2,801,134	0	For
Wellington	1,815,496	0	For
Renaissance	1,644,957	0	For
Avoro Capital Advisors LLC	1,249,329	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,217,495	0	For
Invesco	734,979	0	For
AQR	732,815	0	For
Charles Schwab	703,959	0	For
Victory Capital	556,645	0	For
LSV ASSET MANAGEMENT	523,185	0	For
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	518,236	0	For
Pacer Funds Trust	500,680	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	474,881	0	For
Capitol Series Trust	455,457	0	For
SEI	414,618	5,539	For
AllianceBernstein	415,377	0	For
Thrivent	411,451	0	For
DEERFIELD MANAGEMENT COMPANY, L.P.	386,744	0	For
Northern Trust	368,549	0	For
Amundi	0	345,482	Against
Swedbank Robur Fonder AB	321,405	0	For
First Trust	310,785	1,382	For

Showing the 25 largest of 628 asset managers. See all 628 in the interactive database.

2. APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 36,901,484AGAINST: 3,277,695

UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 3: Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan:”): 36,901,484 for, 3,277,695 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 82% for, 7% against (89% of the company cast a for/against vote).

The 158 asset managers below cast 95% of the shares they voted on this item FOR (16,300,288 for, 845,604 against).

FOR 95%

FOR: 16,300,288 (95.0%)AGAINST: 845,604 (4.9%)ABSTAIN: 12,176 (0.1%)A: 411 (0.0%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STO” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	0	500,680	0	Against
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
Eversept Partners, LP	130,366	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	11,864	84,366	0	Against
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For

Showing the 25 largest of 158 asset managers. See all 158 in the interactive database.

3. Election of Directors: Christopher Causey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%

FOR: 34,893,687AGAINST: 5,296,661

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 34,893,687 for, 5,296,661 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 77% for, 12% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 92% of the shares they voted on this item FOR (15,717,722 for, 1,290,959 against).

FOR 92%8%

FOR: 15,717,722 (92.3%)AGAINST: 1,290,959 (7.6%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Christopher Causey” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	0	232,026	0	Against
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	11,864	84,366	0	Against
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Equitable	83,150	0	0	For
Brighthouse	69,287	482	11,621	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

4. Election of Directors: Christopher Patusky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 35,613,212AGAINST: 4,577,171

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 35,613,212 for, 4,577,171 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 79% for, 10% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 95% of the shares they voted on this item FOR (16,235,927 for, 776,999 against).

FOR 95%

FOR: 16,235,927 (95.4%)AGAINST: 776,999 (4.6%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Christopher Patusky” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

5. Election of Directors: Jan Malcolm

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 39,688,758AGAINST: 500,264

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 39,688,758 for, 500,264 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 88% for, 1% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.7% of the shares they voted on this item FOR (16,978,210 for, 34,716 against).

FOR 99.7%

FOR: 16,978,210 (99.7%)AGAINST: 34,716 (0.2%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Jan Malcolm” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	For
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

6. Election of Directors: Judy Olian

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 39,832,045AGAINST: 357,023

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 39,832,045 for, 357,023 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 88% for, 0.8% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.9% of the shares they voted on this item FOR (17,011,203 for, 1,723 against).

FOR 99.9%

FOR: 17,011,203 (99.9%)AGAINST: 1,723 (0.0%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Judy Olian” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	For
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

7. Election of Directors: Linda Maxwell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 39,715,114AGAINST: 474,450

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 39,715,114 for, 474,450 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 88% for, 1% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.9% of the shares they voted on this item FOR (17,012,925 for, 0 against).

FOR 99.9%

FOR: 17,012,925 (99.9%)AGAINST: 0 (0.0%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Linda Maxwell” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	For
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

8. Election of Directors: Louis Sullivan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%

FOR: 36,302,169AGAINST: 3,875,030

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 36,302,169 for, 3,875,030 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 81% for, 9% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 95% of the shares they voted on this item FOR (16,237,399 for, 775,527 against).

FOR 95%

FOR: 16,237,399 (95.4%)AGAINST: 775,527 (4.6%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Louis Sullivan” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

9. Election of Directors: Martine Rothblatt

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 37,651,671AGAINST: 2,539,840

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 37,651,671 for, 2,539,840 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 84% for, 6% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.5% of the shares they voted on this item FOR (16,943,745 for, 69,181 against).

FOR 99.5%

FOR: 16,943,745 (99.5%)AGAINST: 69,181 (0.4%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Martine Rothblatt” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	147,576	36,433	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

10. Election of Directors: Nilda Mesa

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 39,346,176AGAINST: 833,067

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 39,346,176 for, 833,067 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 87% for, 2% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.9% of the shares they voted on this item FOR (17,007,411 for, 5,515 against).

FOR 99.8%

FOR: 17,007,411 (99.9%)AGAINST: 5,515 (0.0%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Nilda Mesa” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	5,395,458	0	For
BlackRock	2,949,135	0	For
Fidelity	2,104,599	0	For
State Street	723,284	0	For
Pacer Funds Trust	500,680	0	For
Capitol Series Trust	455,457	0	For
Charles Schwab	349,369	0	For
Invesco	331,976	0	For
First Trust	306,613	0	For
Victory Capital	303,730	0	For
TIAA	232,026	0	For
Lord Abbett	220,514	0	For
Thrivent	203,833	0	For
John Hancock	184,009	0	For
AQR	169,911	0	For
SEI	158,418	0	For
JPMorgan	112,335	0	For
Jackson National	96,230	0	For
Dimensional	95,632	0	For
T. Rowe Price	93,546	0	For
Brighthouse	74,014	11,621	For
Equitable	83,150	0	For
AIG/SunAmerica	71,525	0	For
AllianceBernstein	71,517	0	For
Bridge Builder Trust	62,878	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

11. Election of Directors: Ray Kurzweil

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 38,353,526AGAINST: 1,836,845

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 38,353,526 for, 1,836,845 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.6% of the shares they voted on this item FOR (16,946,439 for, 66,487 against).

FOR 99.5%

FOR: 16,946,439 (99.5%)AGAINST: 66,487 (0.4%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Ray Kurzweil” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

12. Election of Directors: Raymond Dwek

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%

FOR: 36,254,579AGAINST: 3,935,774

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 36,254,579 for, 3,935,774 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 80% for, 9% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 95% of the shares they voted on this item FOR (16,195,029 for, 817,897 against).

FOR 95%

FOR: 16,195,029 (95.1%)AGAINST: 817,897 (4.8%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Raymond Dwek” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,457	1	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	2,671	720,613	0	Against
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

13. Election of Directors: Richard Giltner

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%

FOR: 37,971,706AGAINST: 2,218,884

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 37,971,706 for, 2,218,884 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 84% for, 5% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.7% of the shares they voted on this item FOR (16,972,086 for, 40,840 against).

FOR 99.6%

FOR: 16,972,086 (99.7%)AGAINST: 40,840 (0.2%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Richard Giltner” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

14. Election of Directors: Tommy Thompson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 38,598,138AGAINST: 1,590,040

UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 38,598,138 for, 1,590,040 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 86% for, 4% against (89% of the company cast a for/against vote).

The 152 asset managers below cast 99.7% of the shares they voted on this item FOR (16,975,877 for, 37,049 against).

FOR 99.7%

FOR: 16,975,877 (99.7%)AGAINST: 37,049 (0.2%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “Election of Directors: Tommy Thompson” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,395,458	0	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	74,014	0	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 152 asset managers. See all 152 in the interactive database.

15. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 39,345,917AGAINST: 2,142,852

UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 4: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025:”): 39,345,917 for, 2,142,852 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 45,074,551 outstanding shares: 87% for, 5% against (92% of the company cast a for/against vote).

The 151 asset managers below cast 99.8% of the shares they voted on this item FOR (16,967,596 for, 26,536 against).

FOR 99.7%

FOR: 16,967,596 (99.8%)AGAINST: 26,536 (0.2%)ABSTAIN: 12,176 (0.1%)NOT VOTED: 22 (0.0%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	5,394,860	598	0	For
BlackRock	2,949,135	0	0	For
Fidelity	2,104,599	0	0	For
State Street	723,240	44	0	For
Pacer Funds Trust	500,680	0	0	For
Capitol Series Trust	455,457	0	0	For
Charles Schwab	349,369	0	0	For
Invesco	331,976	0	0	For
First Trust	306,613	0	0	For
Victory Capital	303,730	0	0	For
TIAA	232,026	0	0	For
Lord Abbett	220,514	0	0	For
Thrivent	203,833	0	0	For
John Hancock	184,009	0	0	For
AQR	169,911	0	0	For
SEI	158,418	0	0	For
JPMorgan	112,335	0	0	For
Jackson National	96,230	0	0	For
Dimensional	95,632	0	0	For
T. Rowe Price	93,546	0	0	For
Brighthouse	73,532	482	11,621	For
Equitable	83,150	0	0	For
AIG/SunAmerica	71,525	0	0	For
AllianceBernstein	71,517	0	0	For
Bridge Builder Trust	62,878	0	0	For

Showing the 25 largest of 151 asset managers. See all 151 in the interactive database.

16. Audit Related

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (44 for, 0 against).

FOR: 44 (100.0%)

Largest asset managers voting on “Audit Related” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Two Roads Shared Trust	25	0	0	0	For
Members Trust Co	19	0	0	0	For

17. Compensation

COMPENSATIONMajority of the votes cast: yes

96% Majority: yes · of votes cast

FOR 96%

FOR: 38,413,776AGAINST: 1,763,712

The 2 asset managers below cast 100% of the shares they voted on this item FOR (44 for, 0 against).

FOR 100%

FOR: 44 (100.0%)

Largest asset managers voting on “Compensation” at UNITED THERAPEUTICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Two Roads Shared Trust	25	0	0	0	For
Members Trust Co	19	0	0	0	For

Largest UNITED THERAPEUTICS CORP. shareholders voting in 2024-2025

Ranked by the number of UNITED THERAPEUTICS CORP. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 45,074,551 shares outstanding at the time of that meeting.

Top UNITED THERAPEUTICS CORP. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	12.17%
2	BlackRock	11.00%
3	Fidelity	7.35%
4	State Street	6.21%
5	Wellington	4.03%
6	Renaissance	3.65%
7	Avoro Capital Advisors LLC	2.77%
8	GEODE CAPITAL MANAGEMENT, LLC	2.70%
9	Invesco	1.63%
10	AQR	1.63%

Reported UNITED THERAPEUTICS CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

UNITED THERAPEUTICS CORP. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.08%	13F
Vanguard Group	9.89%	13F
Martine Rothblatt	7.09%	DEF14A
Avoro Capital Advisors LLC	6.34%	DEF14A
FMR LLC	5.15%	DEF14A
State Street	4.95%	13F
Renaissance Technologies	4.67%	13F
Wellington Management	4.50%	13F
FMR (Fidelity)	2.54%	13F
Dimensional Fund Advisors	1.39%	13F

Percentages above are of 45,074,551 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At UNITED THERAPEUTICS CORP.'s shareholder meeting held 2025-06-26, in the 2024-2025 proxy season, 635 asset managers reported how they voted in their SEC Form N-PX filings, covering 10,885 separate fund positions. Their filings are grouped here into 17 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.